{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-096820","form_type":"8-K","ticker":"RBOT","cik":"0001812173","company_name":"Vicarious Surgical Inc.","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.746278+00:00","generated_at":"2026-05-30T02:07:40.729817+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Vicarious Surgical Q3 net loss $17.1M; cash $60.9M; on track for system milestone","bullets":["GAAP net loss of $17.1M ($2.90/share); adjusted net loss $17.0M ($2.87/share), improved from $20.4M loss YoY.","Operating expenses $17.8M, down 17% YoY; R&D $10.8M, G&A $5.7M, S&M $1.2M.","Cash and investments $60.9M at Sept 30; Q3 cash burn $12.4M.","Reaffirms full-year 2024 cash burn guidance of ~$50M.","CEO expects Version 1.0 system integration milestone within weeks, first clinical patient in less than a year."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-096820","json":"https://secwatch.observer/filing/0001213900-24-096820.json","markdown":"https://secwatch.observer/filing/0001213900-24-096820.md","text":"https://secwatch.observer/filing/0001213900-24-096820.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1812173/000121390024096820/0001213900-24-096820-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1812173/000121390024096820/ea0219073-8k_vicarious.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:07:40.729817+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}